ABUS vs ORMP

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

ABUS

38.3
AI Score
VS
ABUS Wins

ORMP

33.3
AI Score

Investment Advisor Scores

ABUS

38score
Recommendation
EXTENDED

ORMP

33score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric ABUS ORMP Winner
Forward P/E 10.2459 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -90.6% -100.0% ABUS
Earnings Growth 0.0% 493.5% ORMP
Tradestie Score 38.3/100 33.3/100 ABUS
Profit Margin 84.2% 0.0% ABUS
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED EXTENDED Tie

Relative Price Performance (Last 90 Days)

ABUS 1M: +18.5% · 3M: +19.3% ORMP 1M: +19.5% · 3M: +20.7%

Current Technical Phase

ABUS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.5% over 20 days), RSI 66

RSI (14): 66.2 · Price: $5.19

ORMP

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.0% over 20 days), RSI 69

RSI (14): 69.0 · Price: $4.82

Fundamentals Snapshot

Metric ABUS ORMP
Market Cap
Forward P/E -46.9 0.0
Trailing P/E 6.6 1.2
Revenue (TTM)
Revenue Growth -0.9% -1.0%
Gross Margin 0.9%
Operating Margin -5.7% 0.0%
EPS 0.79 4.13
Dividend Yield 0.00%

Frequently Asked Questions

Based on our detailed analysis, ABUS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.